CATEGORIES: General SLE
First posted June, 2010; Last updated August, 2022
Sponsored by the National Eye Institute, this observational study is looking at whether differences in a person’s genes explain why some people develop toxicity to the retina as a result of treatment with plaquenil while others do not.
To Learn More Contact
Patient Recruitment and Public Liaison Office at 1-800-411-1222 or prpl@mail.cc.nih.gov.
ClinicalTrials.gov identifier: NCT01145196